Related Experiment Video

Updated: Sep 20, 2026

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
05:06

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates

Monique Malléa1, Abdallah Mahamoud, Jacqueline Chevalier

  • 1EA2197, IFR48, Faculté de Médecine, Université de la Méditerranée, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 05, France.

The Biochemical Journal
|September 10, 2003
PubMed

Insights

Multidrug resistance (MDR) in bacteria is a growing threat. Researchers found that alkylaminoquinolines can block bacterial efflux pumps, restoring antibiotic effectiveness against resistant Gram-negative pathogens.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Multidrug resistance (MDR) in microbial pathogens is increasing globally, driven by efflux mechanisms.
  • Bacterial efflux pumps expel drugs across the cell envelope, conferring antibiotic resistance and leading to treatment failures.
  • Blocking these efflux pumps is a promising strategy to combat MDR.

Purpose of the Study:

  • To identify inhibitors of bacterial drug efflux pumps.
  • To evaluate the potential of alkylaminoquinolines in restoring antibiotic susceptibility in MDR Gram-negative bacteria.

Main Methods:

  • Testing various alkylaminoquinolines for their ability to inhibit drug transporters.
  • Conducting antibiotic efflux studies using clinical isolates of MDR Gram-negative bacteria.
  • Identifying specific inhibitors of the AcrAB-TolC efflux pump.

Main Results:

  • Alkylaminoquinolines restored susceptibility to antibiotics in MDR Gram-negative bacteria.
  • 7-nitro-8-methyl-4-[2'-(piperidino)ethyl]aminoquinoline inhibited the AcrAB-TolC efflux pump.
  • This compound increased intracellular drug concentrations and showed activity across diverse resistance phenotypes.

Conclusions:

  • Alkylaminoquinolines are effective inhibitors of bacterial efflux pumps.
  • Targeting efflux pumps with compounds like 7-nitro-8-methyl-4-[2'-(piperidino)ethyl]aminoquinoline offers a viable strategy against MDR infections.

More Related Videos

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes08:23

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...